Sign in

CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company

Akari Therapeutics Plc

Sign in to watch
Ticker
AKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
EIN
981034922
Phone
(929) 274-7510
Business address
401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
Former names
Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
  1. DEF 14A Proxy Proxy Statement
  2. 10-Q Report Quarterly Report
  3. 8-K Event Executive or director change
  4. 8-K Event Delisting notice
  5. RW Other RW
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 8-K Event Other events
  11. 10-K Report Annual Report
  12. 4 Option exercise Director acquired 202,700 shares (option exercise)
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 32 of 38 · 746 filings